{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:35:31Z","timestamp":1783600531113,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071101"],"award-info":[{"award-number":["82071101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002068"],"award-info":[{"award-number":["82002068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272281"],"award-info":[{"award-number":["82272281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010949"],"award-info":[{"award-number":["2021A1515010949"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515011142"],"award-info":[{"award-number":["2021A1515011142"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013153","name":"Shantou Science and Technology Project","doi-asserted-by":"publisher","award":["200624095260243"],"award-info":[{"award-number":["200624095260243"]}],"id":[{"id":"10.13039\/501100013153","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013153","name":"Shantou Science and Technology Project","doi-asserted-by":"publisher","award":["230503176494983"],"award-info":[{"award-number":["230503176494983"]}],"id":[{"id":"10.13039\/501100013153","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04179-8","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:15:07Z","timestamp":1739297707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Induction of the p21\/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma"],"prefix":"10.1186","volume":"16","author":[{"given":"Wanxian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsa","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosha","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genghong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0601-031X","authenticated-orcid":false,"given":"Xiaoping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"4179_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European consensus-based interdisciplinary guideline for melanoma part 1: diagnostics: update 2022. Eur J Cancer. 2022;170:236\u201355.","journal-title":"Eur J Cancer"},{"key":"4179_CR2","unstructured":"http:\/\/www.seer.cancer.gov\/statfacts\/."},{"issue":"9919","key":"4179_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont AM, Spatz A, Robert C. Cutaneous melanoma. The Lancet. 2014;383(9919):816\u201327.","journal-title":"The Lancet"},{"issue":"4","key":"4179_CR4","first-page":"1071","volume":"52","author":"GC Leonardi","year":"2018","unstructured":"Leonardi GC, Falzone L, Salemi R, Zangh\u00ec A, Spandidos DA, Mccubrey JA, et al. Cutaneous melanoma: from pathogenesis to therapy (review). Int J Oncol. 2018;52(4):1071\u201380.","journal-title":"Int J Oncol"},{"issue":"7","key":"4179_CR5","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1056\/NEJMoa1904059","volume":"381","author":"C Robert","year":"2019","unstructured":"Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, Hauschild A, Levchenko E, et al. Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma. N Engl J Med. 2019;381(7):626\u201336.","journal-title":"N Engl J Med"},{"issue":"4","key":"4179_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/annonc\/mdz011","volume":"30","author":"O Hamid","year":"2019","unstructured":"Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, et al. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann Oncol Off J Eur Soc Med Oncol. 2019;30(4):582\u20138.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1","key":"4179_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2010.09.007","volume":"20","author":"PV Dickson","year":"2011","unstructured":"Dickson PV, Gershenwald JE. Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am. 2011;20(1):1\u201317.","journal-title":"Surg Oncol Clin N Am"},{"issue":"11","key":"4179_CR8","first-page":"3862","volume":"6","author":"TC James","year":"1986","unstructured":"James TC, Elgin SC. Identification of a nonhistone chromosomal protein associated with heterochromatin in Drosophila melanogaster and its gene. Mol Cell Biol. 1986;6(11):3862\u201372.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"4179_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1097-2765(01)00218-0","volume":"7","author":"AL Nielsen","year":"2001","unstructured":"Nielsen AL, Oulad-Abdelghani M, Ortiz JA, Remboutsika E, Chambon P, Losson R. Heterochromatin formation in mammalian cells: interaction between histones and HP1 proteins. Mol Cell. 2001;7(4):729\u201339.","journal-title":"Mol Cell"},{"issue":"4","key":"4179_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrm1355","volume":"5","author":"C Maison","year":"2004","unstructured":"Maison C, Almouzni G. HP1 and the dynamics of heterochromatin maintenance. Nat Rev Mol Cell Biol. 2004;5(4):296\u2013304.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"4179_CR11","doi-asserted-by":"publisher","first-page":"7676","DOI":"10.1093\/nar\/gks509","volume":"40","author":"JL Thorne","year":"2012","unstructured":"Thorne JL, Ouboussad L, Lefevre PF. Heterochromatin protein 1 gamma and I\u03baB kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages. Nucleic Acids Res. 2012;40(16):7676\u201389.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"4179_CR12","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1101\/gr.124818.111","volume":"22","author":"A Smallwood","year":"2012","unstructured":"Smallwood A, Hon GC, Jin F, Henry RE, Espinosa JM, Ren B. CBX3 regulates efficient RNA processing genome-wide. Genome Res. 2012;22(8):1426\u201336.","journal-title":"Genome Res"},{"issue":"3","key":"4179_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1101\/gad.292169.116","volume":"31","author":"C Huang","year":"2017","unstructured":"Huang C, Su T, Xue Y, Cheng C, Lay FD, McKee RA, et al. Cbx3 maintains lineage specificity during neural differentiation. Genes Dev. 2017;31(3):241\u20136.","journal-title":"Genes Dev"},{"issue":"11","key":"4179_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015507","volume":"5","author":"M Caillier","year":"2010","unstructured":"Caillier M, Th\u00e9not S, Tribollet V, Birot AM, Samarut J, Mey A. Role of the epigenetic regulator HP1\u03b3 in the control of embryonic stem cell properties. PLoS ONE. 2010;5(11): e15507.","journal-title":"PLoS ONE"},{"issue":"15","key":"4179_CR15","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.18632\/aging.102132","volume":"11","author":"X Zhong","year":"2019","unstructured":"Zhong X, Kan A, Zhang W, Zhou J, Zhang H, Chen J, et al. CBX3\/HP1\u03b3 promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma. Aging. 2019;11(15):5483\u201397.","journal-title":"Aging"},{"issue":"8","key":"4179_CR16","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.7150\/ijbs.68995","volume":"18","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yu H, Ren D, Sun Y, Guo F, Cai H, et al. CBX3 Regulated By YBX1 promotes smoking-induced pancreatic cancer progression via inhibiting SMURF2 expression. Int J Biol Sci. 2022;18(8):3484\u201397.","journal-title":"Int J Biol Sci"},{"key":"4179_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s12967-023-04478-9","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen J, Lin Y, zheng S, Chen Q, Tang S, Zhong X. CBX3 promotes clear cell renal carcinoma through PI3K\/AKT activation and aberrant immunity. J Transl Med. 2023;21:600.","journal-title":"J Transl Med"},{"issue":"9","key":"4179_CR18","doi-asserted-by":"publisher","first-page":"107556","DOI":"10.1016\/j.isci.2023.107556","volume":"26","author":"KJ Zhang","year":"2023","unstructured":"Zhang KJ, Tan XL, Guo L. LncRNA TYMSOS facilitates breast cancer metastasis and immune escape through downregulating ULBP3. iScience. 2023;26(9):107556.","journal-title":"iScience."},{"issue":"6","key":"4179_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, Repe\u010dka K, McDade F, Kamath A, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"271","key":"4179_CR20","doi-asserted-by":"publisher","first-page":"119185","DOI":"10.1016\/j.lfs.2021.119185","volume":"15","author":"J Chen","year":"2021","unstructured":"Chen J, Zhang W, Pan C, Fan J, Zhong X, Tang S. Glaucocalyxin a induces cell cycle arrest and apoptosis via inhibiting NF-\u03baB\/p65 signaling pathway in melanoma cells. Life Sci. 2021;15(271):119185.","journal-title":"Life Sci"},{"issue":"3","key":"4179_CR21","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov Camb Mass. 2021;2(3):100141.","journal-title":"Innov Camb Mass."},{"issue":"6282","key":"4179_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189\u201396.","journal-title":"Science"},{"issue":"5","key":"4179_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"4179_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","volume":"12","author":"J Fu","year":"2020","unstructured":"Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P, et al. Large-scale public data reuse to model immunotherapy response and resistance. Genome Med. 2020;12(1):21.","journal-title":"Genome Med"},{"key":"4179_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115659","volume":"143","author":"AJ van Wijnen","year":"2021","unstructured":"van Wijnen AJ, Bagheri L, Badreldin AA, Larson AN, Dudakovic A, Thaler R, et al. Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development. Bone. 2021;143: 115659.","journal-title":"Bone"},{"issue":"9","key":"4179_CR26","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1038\/s41418-020-0520-5","volume":"27","author":"SA Yi","year":"2020","unstructured":"Yi SA, Lee DH, Kim GW, Ryu HW, Park JW, Lee J, et al. HPV-mediated nuclear export of HP1\u03b3 drives cervical tumorigenesis by downregulation of p53. Cell Death Differ. 2020;27(9):2537\u201351.","journal-title":"Cell Death Differ"},{"issue":"12","key":"4179_CR27","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41419-020-03247-6","volume":"11","author":"H Cai","year":"2020","unstructured":"Cai H, Yu Y, Ni X, Li C, Hu Y, Wang J, et al. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met\/Akt\/mTOR axis. Cell Death Dis. 2020;11(12):1032.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4179_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12967-019-1930-3","volume":"17","author":"S Wang","year":"2019","unstructured":"Wang S, Liu F, Wang Y, Fan W, Zhao H, Liu L, et al. Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma. J Transl Med. 2019;17(1):179.","journal-title":"J Transl Med"},{"issue":"5","key":"4179_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/carcin\/bgab013","volume":"42","author":"Y Huang","year":"2021","unstructured":"Huang Y, Lin Y, Song X, Wu D. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p\/CBX3 axis in diffuse large B-cell lymphoma. Carcinogenesis. 2021;42(5):733\u201341.","journal-title":"Carcinogenesis"},{"issue":"6","key":"4179_CR30","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.3390\/ijms19061768","volume":"19","author":"LY Chen","year":"2018","unstructured":"Chen LY, Cheng CS, Qu C, Wang P, Chen H, Meng ZQ, et al. Overexpression of CBX3 in pancreatic adenocarcinoma promotes cell cycle transition-associated tumor progression. Int J Mol Sci. 2018;19(6):1768.","journal-title":"Int J Mol Sci"},{"key":"4179_CR31","volume":"10","author":"H Liang","year":"2023","unstructured":"Liang H, Yang C, Zeng R, Song Y, Wang J, Xiong W, et al. Targeting CBX3 with a dual BET\/PLK1 inhibitor enhances the antitumor efficacy of CDK4\/6 inhibitors in prostate cancer. Adv Sci Weinh Baden-Wurtt Ger. 2023;10: e2302368.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"issue":"1","key":"4179_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/jcp.29631","volume":"236","author":"Z He","year":"2021","unstructured":"He Z, Chen J, Chen X, Wang H, Tang L, Han C. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53\/P21 pathway. J Cell Physiol. 2021;236(1):107\u201320.","journal-title":"J Cell Physiol"},{"issue":"4","key":"4179_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.molmed.2017.02.001","volume":"23","author":"AG Georgakilas","year":"2017","unstructured":"Georgakilas AG, Martin OA, Bonner WM. p21: a two-faced genome guardian. Trends Mol Med. 2017;23(4):310\u20139.","journal-title":"Trends Mol Med"},{"issue":"5","key":"4179_CR34","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53\u2013p21-RB signaling. Cell Death Differ. 2022;29(5):946\u201360.","journal-title":"Cell Death Differ"},{"issue":"11","key":"4179_CR35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.tcb.2018.07.002","volume":"28","author":"S Goel","year":"2018","unstructured":"Goel S, DeCristo MJ, McAllister SS, Zhao JJ. CDK4\/6 inhibition in cancer: beyond cell cycle arrest. Trends Cell Biol. 2018;28(11):911\u201325.","journal-title":"Trends Cell Biol"},{"issue":"3","key":"4179_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1023\/A:1006396104073","volume":"18","author":"R Halaban","year":"1999","unstructured":"Halaban R. Melanoma cell autonomous growth: the Rb\/E2F pathway. Cancer Metastasis Rev. 1999;18(3):333\u201343.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"4179_CR37","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/jnci\/djs002","volume":"104","author":"PJ Roberts","year":"2012","unstructured":"Roberts PJ, Bisi JE, Strum JC, Combest AJ, Darr DB, Usary JE, et al. Multiple roles of cyclin-dependent kinase 4\/6 inhibitors in cancer therapy. J Natl Cancer Inst. 2012;104(6):476\u201387.","journal-title":"J Natl Cancer Inst"},{"key":"4179_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ctrv.2016.03.002","volume":"45","author":"E Hamilton","year":"2016","unstructured":"Hamilton E, Infante JR. Targeting CDK4\/6 in patients with cancer. Cancer Treat Rev. 2016;45:129\u201338.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"4179_CR39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19(6):326\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4179_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.molcel.2020.08.020","volume":"80","author":"SM Rubin","year":"2020","unstructured":"Rubin SM, Sage J, Skotheim JM. Integrating old and new paradigms of G1\/S control. Mol Cell. 2020;80(2):183\u201392.","journal-title":"Mol Cell"},{"issue":"1","key":"4179_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0092-8674(00)80625-X","volume":"101","author":"HS Zhang","year":"2000","unstructured":"Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI\/SNF and Rb-hSWI\/SNF. Cell. 2000;101(1):79\u201389.","journal-title":"Cell"},{"issue":"6","key":"4179_CR42","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-20-2828","volume":"81","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Jin X, Ma J, Ding D, Huang Z, Sheng H, et al. HDAC5 loss impairs RB repression of pro-oncogenic genes and confers CDK4\/6 inhibitor resistance in cancer. Cancer Res. 2021;81(6):1486\u201399.","journal-title":"Cancer Res"},{"issue":"22","key":"4179_CR43","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1038\/s41388-022-02296-9","volume":"41","author":"W Peng","year":"2022","unstructured":"Peng W, Shi S, Zhong J, Liang H, Hou J, Hu X, et al. CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression. Oncogene. 2022;41(22):3051\u201363.","journal-title":"Oncogene"},{"issue":"18","key":"4179_CR44","doi-asserted-by":"publisher","first-page":"153303381984906","DOI":"10.1177\/1533033819849068","volume":"1","author":"G Lian","year":"2019","unstructured":"Lian G, Chen S, Ouyang M, Li F, Chen L, Yang J. Colon cancer cell secretes EGF to promote M2 polarization of TAM through EGFR\/PI3K\/AKT\/mTOR pathway. Technol Cancer Res Treat. 2019;1(18):1533033819849068.","journal-title":"Technol Cancer Res Treat"},{"issue":"5","key":"4179_CR45","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1111\/ajco.12820","volume":"14","author":"SC Chang","year":"2018","unstructured":"Chang SC, Lai YC, Chen YC, Wang NK, Wang WS, Lai JI. CBX3\/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer. Asia Pac J Clin Oncol. 2018;14(5):e283\u20138.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"16","key":"4179_CR46","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1111\/jcmm.17832","volume":"27","author":"K Liu","year":"2023","unstructured":"Liu K, Zhang S, Gong Y, Zhu P, Shen W, Zhang Q. PSMC4 promotes prostate carcinoma progression by regulating the CBX3-EGFR-PI3K-AKT-mTOR pathway. J Cell Mol Med. 2023;27(16):2437\u201347.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"4179_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41573-022-00582-5","volume":"22","author":"JE Burke","year":"2023","unstructured":"Burke JE, Triscott J, Emerling BM, Hammond GRV. Beyond PI3Ks: targeting phosphoinositide kinases in disease. Nat Rev Drug Discov. 2023;22(5):357\u201386.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4179_CR48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4179_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tips.2023.02.007","volume":"44","author":"MMJ Fallatah","year":"2023","unstructured":"Fallatah MMJ, Law FV, Chow WA, Kaiser P. Small-molecule correctors and stabilizers to target p53. Trends Pharmacol Sci. 2023;44(5):274\u201389.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"4179_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-022-01314-3","volume":"15","author":"H Zhu","year":"2022","unstructured":"Zhu H, Gao H, Ji Y, Zhou Q, Du Z, Tian L, et al. Targeting p53-MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials. J Hematol OncolJ Hematol Oncol. 2022;15(1):91.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"8","key":"4179_CR51","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1126\/sciadv.aaw6171","volume":"5","author":"S Nam","year":"2019","unstructured":"Nam S, Gupta VK, Lee HP, Lee JY, Wisdom KM, Varma S, et al. Cell cycle progression in confining microenvironments is regulated by a growth-responsive TRPV4-PI3K\/Akt-p27Kip1 signaling axis. Sci Adv. 2019;5(8):6171-eaaw6171.","journal-title":"Sci Adv"},{"issue":"4","key":"4179_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41568-022-00442-9","volume":"22","author":"S Kalaora","year":"2022","unstructured":"Kalaora S, Nagler A, Wargo JA, Samuels Y. Mechanisms of immune activation and regulation: lessons from melanoma. Nat Rev Cancer. 2022;22(4):195\u2013207.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4179_CR53","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41590-022-01141-1","volume":"23","author":"AC Huang","year":"2022","unstructured":"Huang AC, Zappasodi R. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance. Nat Immunol. 2022;23(5):660\u201370.","journal-title":"Nat Immunol"},{"issue":"8","key":"4179_CR54","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1161\/ATVBAHA.111.230110","volume":"31","author":"Q Xiao","year":"2011","unstructured":"Xiao Q, Wang G, Yin X, Luo Z, Margariti A, Zeng L, et al. Chromobox protein homolog 3 Is essential for stem cell differentiation to smooth muscles in vitro and in embryonic arteriogenesis. Arterioscler Thromb Vasc Biol. 2011;31(8):1842\u201352.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"4179_CR55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/gtc.12205","volume":"20","author":"H Oshiro","year":"2015","unstructured":"Oshiro H, Hirabayashi Y, Furuta Y, Okabe S, Gotoh Y. Up-regulation of HP1\u03b3 expression during neuronal maturation promotes axonal and dendritic development in mouse embryonic neocortex. Genes Cells. 2015;20(2):108\u201320.","journal-title":"Genes Cells"},{"issue":"1","key":"4179_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13072-018-0187-z","volume":"11","author":"K Oyama","year":"2018","unstructured":"Oyama K, El-Nachef D, Fang C, Kajimoto H, Brown JP, Singh PB, et al. Deletion of HP1\u03b3 in cardiac myocytes affects H4K20me3 levels but does not impact cardiac growth. Epigenetics Chromatin. 2018;11(1):18.","journal-title":"Epigenetics Chromatin"},{"issue":"1","key":"4179_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13072-019-0265-x","volume":"12","author":"M Wiese","year":"2019","unstructured":"Wiese M, Bannister AJ, Basu S, Boucher W, Wohlfahrt K, Christophorou MA, et al. Citrullination of HP1\u03b3 chromodomain affects association with chromatin. Epigenetics Chromatin. 2019;12(1):21.","journal-title":"Epigenetics Chromatin"},{"issue":"39","key":"4179_CR58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-093019-123619","volume":"26","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Cao X. Epigenetic remodeling in Innate Immunity and Inflammation. Annu Rev Immunol. 2021;26(39):279\u2013311.","journal-title":"Annu Rev Immunol"},{"issue":"13","key":"4179_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110569","volume":"38","author":"JC Smith","year":"2022","unstructured":"Smith JC, Sheltzer JM. Genome-wide identification and analysis of prognostic features in human cancers. Cell Rep. 2022;38(13): 110569.","journal-title":"Cell Rep"},{"issue":"7","key":"4179_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc.2017.32","volume":"17","author":"WG Kaelin","year":"2017","unstructured":"Kaelin WG. Common pitfalls in preclinical cancer target validation. Nat Rev Cancer. 2017;17(7):425\u201340.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"4179_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002240","volume":"7","author":"D Venet","year":"2011","unstructured":"Venet D, Dumont JE, Detours V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol. 2011;7(10): e1002240.","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"4179_CR62","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity. 2023;56(10):2188\u2013205.","journal-title":"Immunity"},{"issue":"4","key":"4179_CR63","doi-asserted-by":"publisher","first-page":"20210058","DOI":"10.1002\/EXP.20210058","volume":"3","author":"S Du","year":"2023","unstructured":"Du S, Yan J, Xue Y, Zhong Y, Dong Y. Adoptive cell therapy for cancer treatment. Exploration. 2023;3(4):20210058.","journal-title":"Exploration"},{"issue":"1","key":"4179_CR64","doi-asserted-by":"publisher","first-page":"20210171","DOI":"10.1002\/EXP.20210171","volume":"2","author":"Y Guo","year":"2022","unstructured":"Guo Y, Wang Z, Shi X, Shen M. Engineered cancer cell membranes: an emerging agent for efficient cancer theranostics. Exploration. 2022;2(1):20210171.","journal-title":"Exploration"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04179-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04179-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04179-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:15:11Z","timestamp":1739297711000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04179-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4179"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04179-8","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"29 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The original sources (Alenabio and Cell Bank of the Chinese Academy of Sciences) have confirmed that there was initial ethical approval for collection of these human cells\/ tissues, and that the donors had signed informed consent. The research project was conducted according to the ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments). The animal study was compliant with the protocol of Ethics Committee of Shantou University Medical College (SUMC2020-257). Date of approval is Jan 1, 2021. Title of the approved project: Role of HP1\u03b3 in melanoma development and its molecular mechanism.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors revised and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}